About the Conference

The International Conference on Bioinformatics, Biomedicine, Biotechnology and Computational Biology (EUIC3BCB 2025) will be held on 24-25 January 2025 in Hiroshima, Japan. It is organized by the Eurasia Web Global Research Forum.

The conference is a global forum for researchers, academics, industry leaders and entrepreneurs. It provides a collaborative platform to explore, analyse and discuss the trends transforming Bioinformatics, Biomedicine, Biotechnology and Computational Biology in today’s interconnected research community.

Over two days, participants can present their research in technical sessions, hear keynote addresses from leading experts, and take part in panel discussions and networking sessions. The programme is designed to support professional growth and new research partnerships.

Mode of participation: In-person and virtual (hybrid)
Venue: Hiroshima, Japan

Conference Objectives

• Present cutting-edge research: Provide a platform for scholars and practitioners to share empirical findings, theoretical frameworks and practical case studies.
• Address industry challenges: Discuss real-world obstacles and examine practical solutions for long-term, sustainable business growth.
• Foster global collaboration: Encourage knowledge sharing, networking and cross-disciplinary partnerships among professionals working in an increasingly competitive and digital world.
• Bridge academia and industry: Connect academic research with business practice so findings can be applied in real organisations.
• Support early-career researchers: Give Ph.D. scholars, Academicians, Industry representatives and young researchers the chance to present their work and receive feedback from experts.

Peer review process: All submissions undergo double-blind peer review by at least two reviewers

Plagiarism and ethics policy: Similarity check (e.g. via Turnitin or iThenticate), acceptable limit, publication ethics standard (e.g. COPE)

Certificates: Presentation and participation certificates will be provided.

Who should attend: Academics, researchers, Ph.D. scholars, business professionals, marketers, consultants, policymakers